A U.S. federal judge has denied an injunction that would have allowed compounding pharmacies to keep making copies of Eli ...

A U.S. federal judge has refused to allow compounding pharmacies to keep making copies of Eli Lilly's popular weight-loss and ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...

A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture ...

Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...

The partnership comes as telehealth companies grapple with restrictions on the sale of some compounded GLP-1s.

As a federal court in Texas hears a case pitting the FDA versus compounders who want to continue to manufacture cheaper ...

(This Mar. 6 story has been corrected to clarify that the judge denied an injunction, not barred copies, in the headline) ...

Eli Lilly partnered up with telehealth providers LifeMD and Teladoc Health to offer its lower cost, single-vial ...

A U.S. federal judge has restricted compounding pharmacies from making copies of Eli Lilly's weight-loss and diabetes drugs due to a lawsuit against the FDA's decision that there's no longer a ...

Eli Lilly is now offering four doses of Zepbound in self-administration vials. The lower-cost self-pay option targets people ...

Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...